- Home
- FBRT vs VSTM Comparison
FBRT vs VSTM Comparison
Compare FBRT & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRT | VSTM |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 882.8M | 723.8M |
| IPO Year | 1985 | 2012 |
Fundamental Metrics
Financial Performance| Metric | FBRT | VSTM |
|---|---|---|
| Price | $10.32 | $6.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $14.33 | $13.38 |
| AVG Volume (30 Days) | 766.7K | ★ 2.1M |
| Earning Date | 02-11-2026 | 11-04-2025 |
| Dividend Yield | ★ 13.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $241,051,000.00 | $13,379,000.00 |
| Revenue This Year | $28.41 | $208.54 |
| Revenue Next Year | $58.29 | $251.40 |
| P/E Ratio | $12.88 | ★ N/A |
| Revenue Growth | 32.77 | ★ 33.79 |
| 52 Week Low | $9.65 | $4.01 |
| 52 Week High | $13.58 | $11.25 |
Technical Indicators
Market Signals| Indicator | FBRT | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 53.64 | 36.02 |
| Support Level | $9.83 | $6.68 |
| Resistance Level | $10.37 | $7.26 |
| Average True Range (ATR) | 0.22 | 0.59 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 80.09 | 10.29 |
Price Performance
Historical ComparisonAbout FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.